U.S., July 16 -- ClinicalTrials.gov registry received information related to the study (NCT07706569) titled 'Serum Fetuin-A and COMP Levels in Knee Osteoarthritis' on July 11.
Brief Summary: The purpose of this study is to investigate the relationship between the clinical and radiographic severity of knee osteoarthritis (OA) and the serum levels of specific biomarkers, namely Fetuin-A and Cartilage Oligomeric Matrix Protein (COMP). Osteoarthritis is a degenerative joint disease characterized by cartilage breakdown and low-grade inflammation. Investigating these biomarkers may help healthcare providers better understand the disease pathology, potentially leading to earlier diagnosis and improved tracking of disease progression. The study wi...